Colorectal resection represents a cornerstone of modern gastrointestinal surgery for neoplastic and benign diseases. However, anastomotic leakage remains one of the most feared postoperative complications for surgeons worldwide. Despite major advances in minimally invasive techniques and enhanced recovery protocols, anastomotic breakdown still causes significant morbidity, prolonged hospitalization, and increased mortality. Consequently, researchers continually explore novel biomaterial strategies to reinforce surgical repair. A recent experimental study investigates a bioengineered matrix to improve colonic anastomotic healing through sustained pharmacological delivery. Specifically, by incorporating melatonin into a biodegradable poly(lactic-co-glycolic acid) scaffold, investigators created a targeted local therapy that supports structural recovery and tissue integrity.

The Challenge of Anastomotic Dehiscence in Colorectal Surgery

Colorectal surgery demands precise technical execution to ensure secure intestinal continuity. Nevertheless, anastomotic leaks occur in approximately 3% to 15% of patients undergoing lower gastrointestinal resections. Factors such as localized tissue ischemia, bacterial colonization, poor nutritional status, and systemic inflammation contribute to this clinical problem. Furthermore, an anastomotic breakdown releases bowel contents into the peritoneal cavity, triggering peritonitis, sepsis, and multiorgan failure. Consequently, affected patients face substantial setbacks, including emergency re-laparotomy, permanent stoma creation, and compromised oncological outcomes. Although surgeons utilize mechanical staple lines, suture reinforcements, and prophylactic antibiotics, these measures do not completely eliminate tissue failure. In fact, the intrinsic biological repair process requires robust microvascular perfusion, coordinated cellular proliferation, and rapid collagen deposition during early recovery. Therefore, surgical researchers have turned their attention toward localized adjunctive treatments. Specifically, these bioengineered modalities deliver therapeutic agents directly to the suture line, accelerating tissue repair without producing systemic toxicities.

Biomaterial Innovations in Colonic Anastomotic Healing

To address persistent mechanical and biological vulnerabilities, investigators engineered a biodegradable poly(lactic-co-glycolic acid) polymer matrix. PLGA offers distinct advantages because human tissues naturally metabolize its degradation products through routine physiological pathways. Moreover, the scaffold provides sustained, predictable release kinetics of encapsulated therapeutic molecules over several critical days. In this experimental study, researchers evaluated the scaffold in seventy-two male Wistar albino rats divided into three distinct groups. The control cohort underwent standard colonic anastomosis alone, while the second group received an unloaded PLGA matrix. Meanwhile, the third cohort received the anastomosis wrapped with the novel melatonin-loaded PLGA matrix. Subsequently, investigators harvested the anastomotic bowel segments on postoperative days 3 and 7 to assess structural integrity. Specifically, the researchers measured colonic bursting pressure as the primary functional parameter of mechanical strength. Consequently, the results revealed that the melatonin-loaded matrix significantly enhanced colonic bursting pressure by postoperative day 7 compared to control cohorts. In addition, this mechanical reinforcement indicates superior structural stabilization during the critical window when natural tensile strength is otherwise lowest.

Mechanistic Actions: Inflammation Modulation and Oxidative Balance

The physiological benefits of melatonin extend far beyond its classic role as a circadian neurohormone. In fact, melatonin functions as a potent antioxidant, free radical scavenger, and immune modulator in healing tissues. In this study, sustained delivery of melatonin significantly reduced the gene expression of pro-inflammatory cytokines at the anastomotic site. For example, excessive early inflammation often triggers premature tissue degradation, which compromises structural sutures. Furthermore, the melatonin-loaded matrix modulated inducible nitric oxide synthase, cyclooxygenase-2, and myeloperoxidase levels on both postoperative days 3 and 7. By downregulating these inflammatory enzymes, the treatment restrained excessive neutrophilic infiltration and prevented severe cellular injury. In addition, the researchers observed a marked decrease in heme oxygenase-1 and catalase expression by postoperative day 7. This finding suggests that melatonin effectively quenched early reactive oxygen species, thereby reducing the subsequent demand for secondary endogenous antioxidant enzymes. As a result, the local microenvironment transitioned rapidly from a destructive inflammatory phase to a constructive proliferative repair phase.

Extracellular Matrix Remodeling and Collagen Deposition Dynamics

Successful intestinal wound repair ultimately depends on the synthesis, maturation, and organization of extracellular matrix components. In this investigation, the melatonin-loaded PLGA scaffold directly stimulated collagen synthesis at the anastomotic margin. Specifically, the sustained release of melatonin promoted mature collagen deposition through the significant upregulation of arginase-1. Notably, arginase-1 directs cellular metabolism toward L-ornithine and polyamine production, which directly drives collagen formation and fibroblastic activity. Moreover, the novel matrix regulated the expression of a disintegrin and metalloproteinase domain-containing protein 10 and protein 17. These enzymes, known as ADAM10 and ADAM17, govern cell-surface protein shedding, cytokine release, and extracellular matrix remodeling. Consequently, by balancing these proteolytic pathways, the bioabsorbable matrix prevented uncontrolled tissue breakdown while fostering organized matrix architecture. Histological evaluations directly confirmed these molecular findings, revealing denser collagen bundles, improved neo-vascularization, and superior mucosal re-epithelialization in treated specimens. Thus, the matrix created ideal biochemical conditions for resilient structural regeneration.

Translational Potential and Implications for Surgical Practice

The experimental findings carry meaningful clinical implications for colorectal and gastrointestinal surgeons. Anastomotic leakage remains an unsolved dilemma that carries immense emotional and economic burdens for surgical patients. Currently, surgeons possess limited intraoperative interventions that can biologically safeguard a newly constructed anastomosis. Therefore, developing a biocompatible, localized drug-delivery matrix represents a logical and practical step forward. Because PLGA is already approved in numerous clinical devices, translational barriers to human surgical trials are lower than those of entirely novel synthetic compounds. Additionally, melatonin provides a high safety margin, devoid of immunosuppressive complications or cytotoxic risks seen with other pharmacological agents. For instance, in high-risk clinical scenarios—such as emergency bowel resections, prior pelvic radiation, or severe malnutrition—such a matrix could serve as an essential prophylactic barrier. Future clinical trials must evaluate whether wrapping the staple line or suture perimeter with this matrix can reduce real-world leak rates in human colorectal patients. Consequently, this biomaterial platform opens an exciting therapeutic frontier in gastrointestinal surgery.

Frequently Asked Questions

Why is anastomotic leakage such a dangerous complication in colorectal surgery?

Anastomotic leakage allows intraluminal fecal bacteria and intestinal fluids to escape directly into the sterile peritoneal cavity. Consequently, this contamination triggers severe localized peritonitis, abdominal abscess formation, systemic sepsis, and potentially fatal septic shock. Furthermore, leaks frequently mandate urgent revision surgeries and temporary stomas. These devastating complications prolong hospital recovery, increase overall healthcare costs, and adversely affect long-term survival in colorectal cancer patients.

How does melatonin improve tissue repair at the colonic surgical site?

Melatonin functions as an exceptional anti-inflammatory molecule and powerful free radical scavenger in wounded tissues. Specifically, it downregulates destructive inflammatory cytokines, reduces myeloperoxidase activity, and tempers oxidative cell damage during early wound phases. Furthermore, melatonin upregulates arginase-1 expression, which accelerates amino acid pathways dedicated to collagen production. Consequently, fibroblasts deposit organized collagen fibers more rapidly, significantly increasing mechanical bursting pressure and promoting durable tissue strength.

What advantages does a PLGA matrix offer over systemic drug administration?

Systemic administration of drugs often suffers from rapid hepatic clearance, fluctuating serum concentrations, and potential off-target adverse effects. In contrast, a biodegradable PLGA matrix provides localized, continuous drug release directly at the fragile anastomotic margin. Moreover, PLGA degrades harmlessly into lactic acid and glycolic acid without producing local toxicity. This targeted delivery maximizes therapeutic drug concentrations exactly where healing occurs, eliminating systemic side effects and improving surgical safety.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.

References

1. Demir U et al. Enhancing colonic anastomotic healing with a novel melatonin-loaded PLGA matrix. Exp Physiol. 2026 Sep 27. doi: 10.1113/EP093987. PMID: 42801278.


2. Bosmans JWAM, et al. Novel strategies to improve colorectal anastomotic healing. Eur J Surg Oncol. 2020;46(8):1414-1422.


3. Ersoy OF, et al. Effects of melatonin on cytokine release and healing of colonic anastomoses in an experimental sepsis model. Ulus Travma Acil Cerrahi Derg. 2016;22(4):315-321.